An Unusual Cause of a Prolonged Activated Coagulation Time During Cardiac Surgery: Congenital Hypofibrinogenemia

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 22, Issue 5, 2008, Pages 725-726

  Rani, Tippana Radha ^a   Gopinath, Ramachandran ^a  

^a NIZAM'S INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

activated coagulation time; cardiopulmonary bypass; congenital hypofibrinogenemia

Indexed keywords

DIAZEPAM; FENTANYL; FIBRINOGEN; HEPARIN; INOTROPIC AGENT; MIDAZOLAM; PANCURONIUM; PROMETHAZINE; PROTAMINE SULFATE; RANITIDINE; THIOPENTAL; TRAMADOL;

ADULT; ANTICOAGULATION; ARTICLE; BLEEDING TIME; BLOOD CLOTTING DISORDER; BLOOD CLOTTING TIME; CANNULATION; CARDIOPLEGIA; CARDIOPULMONARY BYPASS; CASE REPORT; CRYOANESTHESIA; CRYOPRECIPITATE; DYSPNEA; EVENING DOSAGE; FIBRINOGEN BLOOD LEVEL; HEART ATRIUM SEPTUM DEFECT; HEART EJECTION FRACTION; HEART SURGERY; HEMOSTASIS; HEPARINIZATION; HUMAN; HYPOFIBRINOGENEMIA; LOW DRUG DOSE; LUNG INFECTION; MALE; MORNING DOSAGE; PARTIAL THROMBOPLASTIN TIME; PREMEDICATION; PRIORITY JOURNAL; PROTHROMBIN TIME; THROMBOCYTE COUNT;

ADULT; AFIBRINOGENEMIA; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; HEART SEPTAL DEFECTS, ATRIAL; HUMANS; MALE; WHOLE BLOOD COAGULATION TIME;

EID: 52149091971     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jvca.2007.09.018     Document Type: Article

References (9)

1. Leeners J.V., Mossakowski J., and Kayser S. Case report of congenital afibrinogenemia [German]. Klin Padiatr 207 (1995) 34-35
2. Jobes D.R., Ellison N., and Campbell F.W. Limit(ation)s for ACT. Anesth Analg 69 (1989) 142-144
3. Zucker M.L., Jobes C., Siegel M., et al. Activated clotting time (ACT) testing: Analysis of reproducibility. J Extra Corpor Technol 31 (1999) 130-134
4. Tsukamoto S., Shindo S., Obana M., et al. Fibrinogen level and its influence on cardiopulmonary bypass in surgery for aortic dissection. Jpn J Cardiovasc Surg 32 (2003) 121-125
5. Khaldi F., Toumi N.H., Bouguerra F., et al. Genetic study of congenital afibrinogenemia. Review of 12 cases [French]. Ann Pediatr (Paris) 38 (1991) 461-467
6. Harvey R.G., and Daniel G.C. Hereditary abnormalities of fibrinogen. In: Ernest B., Lichtman M.A., Coller B.S., et al. (Eds). Williams Hematology (1995), McGraw-Hill, New York, NY 1439-1441
7. Menitove J.E., Gill J.C., and Montgomery R.R. Preparation and clinical use of plasma fractions. In: Ernest B., Lichtman M.A., Coller B.S., et al. (Eds). Williams Hematology (1995), McGraw-Hill, New York, NY 1649-1663
8. Domenico P., and Rita P. Point-of-care testing of hemostasis in cardiac surgery. Thrombosis Journal [serial on the internet] (2003). http://www.thrombosisjournal.com/content/1/1/1 Accessed May 6
9. de Jong M.A. High-dose thrombin time versus the activated clotting time during cardiopulmonary bypass. NeSECC J 23 (1998) 10-13